Filing Details

Accession Number:
0001209191-18-039730
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-06-27 20:00:37
Reporting Period:
2018-06-25
Accepted Time:
2018-06-27 20:00:37
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
876378 Transenterix Inc. TRXC Surgical & Medical Instruments & Apparatus (3841) 112962080
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1584367 Todd Pope C/O Transenterix, Inc.
635 Davis Drive, Suite 300
Morrisville NC 27560
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-06-25 138,555 $0.35 454,627 No 4 M Direct
Common Stock Disposition 2018-06-25 100,000 $4.35 354,627 No 4 S Direct
Common Stock Acquisiton 2018-06-25 61,445 $0.35 416,072 No 4 M Direct
Common Stock Disposition 2018-06-25 100,000 $4.85 316,072 No 4 S Direct
Common Stock Acquisiton 2018-06-26 160,086 $0.35 476,158 No 4 M Direct
Common Stock Disposition 2018-06-26 160,086 $5.35 316,072 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option Disposition 2018-06-25 138,555 $0.00 138,555 $0.35
Common Stock Stock Option Disposition 2018-06-25 61,445 $0.00 61,445 $0.35
Common Stock Stock Option Disposition 2018-06-26 160,086 $0.00 160,086 $0.35
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2015-03-02 2022-04-12 No 4 M Direct
221,258 2013-06-02 2022-04-12 No 4 M Direct
61,172 2014-10-02 2022-04-12 No 4 M Direct
Footnotes
  1. The identified transactions set forth on this Form 4 were made pursuant to a Rule 10b5-1(c) sales plan executed by the reporting person on August 9, 2017, as amended on September 20, 2017.
  2. Following the sales on June 25, 2018 and June 26, 2018, the reporting person continues to beneficially own 316,072 shares of the company's common stock. The reporting person also holds stock options to acquire 4,035,262 shares of common stock, of which approximately 47% are vested, and restricted stock units representing an additional 2,226,555 shares of common stock subject to forfeiture restrictions.